Bank of New York Mellon Corp Has $1,680,000 Stake in Fluidigm Corp. (FLDM)
Bank of New York Mellon Corp boosted its position in Fluidigm Corp. (NASDAQ:FLDM) by 3.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 185,974 shares of the company’s stock after buying an additional 5,419 shares during the period. Bank of New York Mellon Corp owned 0.64% of Fluidigm Corp. worth $1,680,000 as of its most recent SEC filing.
A number of other institutional investors have also recently made changes to their positions in FLDM. Stoneridge Investment Partners LLC bought a new stake in Fluidigm Corp. during the second quarter valued at $220,000. Iguana Healthcare Management LLC bought a new stake in Fluidigm Corp. during the first quarter valued at $782,000. Jacobs Levy Equity Management Inc. bought a new stake in Fluidigm Corp. during the first quarter valued at $371,000. Bogle Investment Management L P DE increased its stake in Fluidigm Corp. by 1.0% in the first quarter. Bogle Investment Management L P DE now owns 266,923 shares of the company’s stock valued at $2,154,000 after buying an additional 2,710 shares during the period. Finally, Wellington Management Group LLP increased its stake in Fluidigm Corp. by 28.6% in the first quarter. Wellington Management Group LLP now owns 961,070 shares of the company’s stock valued at $7,756,000 after buying an additional 213,670 shares during the period. 93.33% of the stock is owned by institutional investors and hedge funds.
Fluidigm Corp. (NASDAQ:FLDM) traded down 1.27% during midday trading on Friday, hitting $7.75. 47,131 shares of the stock traded hands. Fluidigm Corp. has a 52 week low of $4.84 and a 52 week high of $12.09. The stock’s 50-day moving average price is $8.55 and its 200-day moving average price is $9.16. The stock’s market capitalization is $225.03 million.
Fluidigm Corp. (NASDAQ:FLDM) last announced its quarterly earnings results on Thursday, August 4th. The company reported ($0.64) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.58) by $0.06. The firm had revenue of $28.20 million for the quarter, compared to analysts’ expectations of $29.62 million. Fluidigm Corp. had a negative net margin of 52.04% and a negative return on equity of 45.68%. The company’s quarterly revenue was down 1.5% on a year-over-year basis. During the same period in the previous year, the company earned ($0.53) EPS. Equities research analysts expect that Fluidigm Corp. will post ($2.32) EPS for the current fiscal year.
Several equities research analysts have weighed in on the stock. Cantor Fitzgerald decreased their price target on shares of Fluidigm Corp. from $13.00 to $11.00 and set a “buy” rating for the company in a research note on Friday, August 5th. Zacks Investment Research raised shares of Fluidigm Corp. from a “sell” rating to a “hold” rating in a research note on Wednesday, September 14th. Finally, Mizuho lifted their price target on shares of Fluidigm Corp. from $11.00 to $12.00 and gave the company a “buy” rating in a research note on Friday, August 5th. Three investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $13.76.
About Fluidigm Corp.
Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.
Want to see what other hedge funds are holding FLDM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fluidigm Corp. (NASDAQ:FLDM).
Receive News & Ratings for Fluidigm Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm Corp. and related companies with MarketBeat.com's FREE daily email newsletter.